OpenAI launches GPT-Rosalind, a specialized AI model for biology research. It aims to help scientists analyze vast genomic data and complex literature, connect genotypes to phenotypes, and identify drug targets. The model is designed with enhanced critical thinking to reject low-value queries. OpenAI acknowledges challenges like AI hallucinations and biosecurity risks, implementing strict U.S.-only access controls initially.